BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25614211)

  • 21. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
    Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
    Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.
    Magro G; Schiappacassi M; Perissinotto D; Corsaro A; Borghese C; Belfiore A; Colombatti A; Grasso S; Botti C; Bombardieri E; Perris R
    J Pathol; 2003 Jul; 200(3):357-69. PubMed ID: 12845632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes].
    Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Mcl-1 and Ki-67 in Papillary Thyroid Carcinomas.
    Maia FF; Vassallo J; Pinto GA; Pavin EJ; Matos PS; Zantut-Wittmann DE
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):209-14. PubMed ID: 27123780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma.
    Hu YJ; Luo XY; Yang Y; Chen CY; Zhang ZY; Guo X
    Genet Mol Res; 2015 Nov; 14(4):15325-30. PubMed ID: 26634497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
    Oliveira G; Polónia A; Cameselle-Teijeiro JM; Leitão D; Sapia S; Sobrinho-Simões M; Eloy C
    Virchows Arch; 2017 May; 470(5):517-525. PubMed ID: 28236059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism.
    Santos-Silva F; Fonseca A; Caffrey T; Carvalho F; Mesquita P; Reis C; Almeida R; David L; Hollingsworth MA
    Glycobiology; 2005 May; 15(5):511-7. PubMed ID: 15604091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papillary thyroid carcinoma expressing CD20.
    Sasaki Y; Seto M; Miyoshi H; Okada S; Yokoyama S; Ohshima A; Ohshima K
    Pathol Int; 2017 Jul; 67(7):350-354. PubMed ID: 28618063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes.
    Liu J; Yi B; Zhang Z; Cao Y
    Front Med; 2016 Jun; 10(2):204-11. PubMed ID: 27090911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications.
    Pickett CA; Agoff SN; Widman TJ; Bronner MP
    Thyroid; 2005 May; 15(5):461-73. PubMed ID: 15929668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions.
    Cao Y; Karsten U; Otto G; Bannasch P
    Virchows Arch; 1999 Jun; 434(6):503-9. PubMed ID: 10394884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer.
    Lu Y; Moreira AL; Hatzoglou V; Stambuk HE; Gonen M; Mazaheri Y; Deasy JO; Shaha AR; Tuttle RM; Shukla-Dave A
    Thyroid; 2015 Jun; 25(6):672-80. PubMed ID: 25809949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-based molecular classification of papillary thyroid carcinoma.
    Rosignolo F; Memeo L; Monzani F; Colarossi C; Pecce V; Verrienti A; Durante C; Grani G; Lamartina L; Forte S; Martinetti D; Giuffrida D; Russo D; Basolo F; Filetti S; Sponziello M
    Int J Oncol; 2017 May; 50(5):1767-1777. PubMed ID: 28393181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
    Guarino V; Faviana P; Salvatore G; Castellone MD; Cirafici AM; De Falco V; Celetti A; Giannini R; Basolo F; Melillo RM; Santoro M
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5270-8. PubMed ID: 15998773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole.
    Richter DU; Jeschke U; Makovitzky J; Gerber B; Briese V
    Anticancer Res; 2007; 27(4A):2001-3. PubMed ID: 17649812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
    Rodriguez MC; Yegorova S; Pitteloud JP; Chavaroche AE; André S; Ardá A; Minond D; Jiménez-Barbero J; Gabius HJ; Cudic M
    Biochemistry; 2015 Jul; 54(29):4462-74. PubMed ID: 26129647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.